← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	ONCS 76 DELISTED OncoSec Medical Incorporated ONCS	34	+3	+10%	$36.2M
77	77 INmune Bio INMB $45.8M	33	+7	+27%	$15.5M
78	78 DELISTED Scorpius Holdings, Inc. SCPX	32	+10	+45%	$19.2M
79	79 Capricor Therapeutics CAPR $423M	30	+5	+20%	$20.5M
80	ACHL 80 DELISTED Achilles Therapeutics ACHL	29	+29	–	$278M
81	BLCM 81 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	29	-5	-15%	$5.14M
82	SCPS 82 DELISTED Scopus BioPharma Inc. Common Stock SCPS	28	+24	+600%	$4.89M
83	83 Opus Genetics IRD $337M	27	+13	+93%	$5.27M
84	84 Enlivex Ltd ENLV $4.46M	23	+12	+109%	$11.7M
85	RCOR 85 DELISTED Renovacor, Inc. RCOR	22	+3	+16%	$49.1M
86	86 BioCardia BCDA $14.2M	19	+3	+19%	$13.5M
87	FRLN 87 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	19	-1	-5%	$144M
88	88 Benitec Biopharma BNTC $295M	14	+2	+17%	$1.84M
89	KRBP 89 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	11	+4	+57%	$3.34M
90	LGVN 90 Longeveron LGVN $4.78M	9	+9	–	$561K
91	91 Eterna Therapeutics ERNA $2.53M	7	+2	+40%	$555K
92	CYAD 92 DELISTED Celyad Oncology SA American Depositary Shares CYAD	6	-1	-14%	$5.46M
93	93 NewcelX Ltd NCEL $16.5M	3	+3	–	$283K
94	94 DELISTED Arcellx ACLX	–	–	–	–
95	95 Artiva Biotherapeutics ARTV $296M	–	–	–	–
96	96 BioRestorative Therapies BRTX $2.02M	–	–	–	–
97	97 Candel Therapeutics CADL $682M	–	–	–	–
98	98 Creative Medical Technology CELZ $6.21M	–	–	–	–
99	99 DELISTED CERo Therapeutics CERO	–	–	–	–
100	100 Calidi Biotherapeutics CLDI $2.25M	–	–	–	–